Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2014
|
| In: |
Annals of oncology
Year: 2014, Volume: 25, Issue: 3, Pages: 682-688 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdu003 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/annonc/mdu003
|
| Author Notes: | J.B. Vermorken, F. Peyrade, J. Krauss, R. Mesía, E. Remenar, T.C. Gauler, U. Keilholz, J.P. Delord, P. Schafhausen, J. Erfán, T.H. Brümmendorf, L. Iglesias, U. Bethe, C. Hicking and P.M. Clement |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1526169673 | ||
| 003 | DE-627 | ||
| 005 | 20220812163509.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160223s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdu003 |2 doi | |
| 035 | |a (DE-627)1526169673 | ||
| 035 | |a (DE-576)456169679 | ||
| 035 | |a (DE-599)BSZ456169679 | ||
| 035 | |a (OCoLC)1340901005 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Vermorken, Jan B. |e VerfasserIn |0 (DE-588)142905747 |0 (DE-627)704339668 |0 (DE-576)334003709 |4 aut | |
| 245 | 1 | 0 | |a Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck |b results of the randomized phase I/II ADVANTAGE trial (phase II part) |c J.B. Vermorken, F. Peyrade, J. Krauss, R. Mesía, E. Remenar, T.C. Gauler, U. Keilholz, J.P. Delord, P. Schafhausen, J. Erfán, T.H. Brümmendorf, L. Iglesias, U. Bethe, C. Hicking and P.M. Clement |
| 264 | 1 | |c 2014 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.02.2016 | ||
| 700 | 1 | |a Krauß, Jürgen |d 1960- |e VerfasserIn |0 (DE-588)120665301 |0 (DE-627)70490778X |0 (DE-576)292329083 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 25(2014), 3, Seite 682-688 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck results of the randomized phase I/II ADVANTAGE trial (phase II part) |
| 773 | 1 | 8 | |g volume:25 |g year:2014 |g number:3 |g pages:682-688 |g extent:7 |a Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck results of the randomized phase I/II ADVANTAGE trial (phase II part) |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/annonc/mdu003 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20160223 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 120665301 |a Krauß, Jürgen |m 120665301:Krauß, Jürgen |d 910000 |e 910000PK120665301 |k 0/910000/ |p 3 | ||
| 999 | |a KXP-PPN1526169673 |e 2899697633 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"7 S."}],"relHost":[{"origin":[{"publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedKey":"1990","dateIssuedDisp":"1990-"}],"id":{"issn":["1569-8041"],"eki":["320428796"],"zdb":["2003498-2"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology","title_sort":"Annals of oncology"}],"pubHistory":["1.1990 -"],"part":{"issue":"3","pages":"682-688","year":"2014","extent":"7","text":"25(2014), 3, Seite 682-688","volume":"25"},"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck results of the randomized phase I/II ADVANTAGE trial (phase II part)Annals of oncology","recId":"320428796","corporate":[{"role":"isb","display":"European Society for Medical Oncology","roleDisplay":"Herausgebendes Organ"}],"language":["eng"]}],"name":{"displayForm":["J.B. Vermorken, F. Peyrade, J. Krauss, R. Mesía, E. Remenar, T.C. Gauler, U. Keilholz, J.P. Delord, P. Schafhausen, J. Erfán, T.H. Brümmendorf, L. Iglesias, U. Bethe, C. Hicking and P.M. Clement"]},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"id":{"eki":["1526169673"],"doi":["10.1093/annonc/mdu003"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 23.02.2016"],"recId":"1526169673","language":["eng"],"person":[{"roleDisplay":"VerfasserIn","display":"Vermorken, Jan B.","role":"aut","family":"Vermorken","given":"Jan B."},{"roleDisplay":"VerfasserIn","display":"Krauß, Jürgen","role":"aut","family":"Krauß","given":"Jürgen"}],"title":[{"title":"Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck","subtitle":"results of the randomized phase I/II ADVANTAGE trial (phase II part)","title_sort":"Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck"}]} | ||
| SRT | |a VERMORKENJCISPLATIN52014 | ||